课题基金 / 基金详情

Pre-clinical development of a novel class of broad-spectrum natural product antivirals

Pre-clinical development of a novel class of broad-spectrum natural product antivirals
一类新型广谱天然产物抗病毒药物的临床前开发
批准号:
480228
负责人:
Jean François
金额:
$57.4万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-03-01 至 2026-03-01

项目摘要

项目成果

Jean François的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Emerging human viruses such as SARS-CoV-2 (cause of COVID-19), influenza A virus (acute respiratory infection), and Zika virus (microcephaly and other congenital malformations), have had an enormous impact on human health. The World Health Organization (
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pre-clinical development of broad-spectrum antiviral strategies against human respiratory viruses of pandemic concern
  • 批准号:
    462582
  • 项目类别:
    Operating Grants
  • 资助金额:
    $68.88万
  • 财政年份:
    2022
  • 负责人:
    Jean François
  • 依托单位:
Development and application of mass-spectrometry-based multiplexing assays for detecting Zika virus and uncovering novel anti-flaviviral strategies
  • 批准号:
    366553
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2016
  • 负责人:
    Jean François
  • 依托单位:
Molecular and cellular studies of novel subtilase-directed secretory pathway serpins
  • 批准号:
    178316
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2008
  • 负责人:
    Jean François
  • 依托单位:
海外基金